• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLATIP MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLATIP MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number 86493
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Event Date 03/20/2020
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that the patient experienced a pericardial effusion.During an ablation procedure with an intellatip mifi open-irrigated standard curve via a non-boston scientific 8.5f sheath on the anterior wall/roof of the left atrium (la), la mapping was performed with an intellamap orion catheter.A woven diagnostic electrode catheter was also being used at the time of event.Ablation was then performed with the intellanav mifi oi.Eventually, during ablation of the la anterior wall/roof, anesthesia told the electrophysiologist (ep) that the patient's blood pressure was low.The ep immediately halted radiofrequency (rf) delivery, performed a transthoracic echocardiogram (tee) and noted an acute (small/"trace") pericardial effusion.Anticoagulation therapy was immediately reversed and further imaging intervention was performed (tee) and the pericardium was accessed.Blood was removed from the pericardium and transfused back to the patient.The effusion would not resolve after over an hour of monitoring.The patient continued to deteriorate and cardiothoracic (ct) surgery was consulted.After further deterioration, the patient was sent for ct surgery.The physician did not attribute the event to any specific product.The catheters were disposed of and are not available for return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLATIP MIFI OPEN-IRRIGATED
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key9953653
MDR Text Key187528304
Report Number2134265-2020-04997
Device Sequence Number1
Product Code OAD
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150005/S008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number86493
Device Catalogue Number86493
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/20/2020
Initial Date FDA Received04/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-